Top compounds associated with response to CCDC169-SOHLH2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.032	0.3
mRNA	PHA-793887	CTRPv2	pan-cancer	AAC	0.029	0.3
mRNA	YM-155	CTRPv2	pan-cancer	AAC	-0.035	0.3
mRNA	Bexarotene	CTRPv2	pan-cancer	AAC	0.034	0.3
mRNA	tamatinib	CTRPv2	pan-cancer	AAC	-0.035	0.3
mRNA	Topotecan	CTRPv2	pan-cancer	AAC	0.029	0.4
mRNA	BRD9876:MK-1775 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.098	0.4
mRNA	Bortezomib	CTRPv2	pan-cancer	AAC	0.032	0.4
mRNA	NPC-26	CTRPv2	pan-cancer	AAC	0.036	0.4
mRNA	Doxorubicin	CTRPv2	pan-cancer	AAC	0.027	0.4

Download CSV